Inovio Pharmaceuticals, Inc. (INO)
2.06
-0.07
(-3.29%)
USD |
NASDAQ |
Dec 12, 16:00
2.10
+0.04
(+1.94%)
After-Hours: 20:00
Inovio Pharmaceuticals Research and Development Expense (Quarterly): 12.98M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agenus, Inc. | 23.60M |
| Arcturus Therapeutics Holdings, Inc. | 19.38M |
| Capricor Therapeutics, Inc. | 20.11M |
| AIM ImmunoTech, Inc. | 0.525M |
| Protalix Biotherapeutics, Inc. | 4.467M |